Literature DB >> 21666196

Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies.

Shyam Raj Upreti1, Kusum Thapa, Yasho Vardan Pradhan, Geeta Shakya, Yuddha Dhoj Sapkota, Abhijeet Anand, Thomas Taylor, Ondrej Mach, Susan Reef, Sirima Pattamadilok, Jayantha Liyanage, Patrick O'Connor, Tika Sedai, Sagar Ram Bhandary, Jeffrey Partridge, William Schluter.   

Abstract

BACKGROUND: The Government of Nepal is interested in preventing congenital rubella syndrome (CRS). Surveillance data were analyzed and studies conducted to assess the burden of rubella and CRS and aid in developing a rubella vaccination strategy.
METHODS: (1) Analysis of rubella cases reported through measles surveillance, 2004-2009; (2) in 2008, rubella seroprevalence among women 15 to 39 years of age was evaluated; and (3) in 2009, children attending a school for the deaf were examined for ocular defects associated with CRS.
RESULTS: From 2004-2009, there were 3,710 confirmed rubella cases and more than 95% of these cases were less than 15 years of age. Of 2,224 women of childbearing age (WCBA) tested for anti-rubella IgG, 2,020 (90.8%) were seropositive. Using a catalytic infection model, approximately 1,426 infants were born with CRS (192/100,000 live births) in 2008. Among 243 students attending a school for the deaf, 18 (7.4%) met the clinical criteria for CRS.
CONCLUSIONS: Rubella and CRS were documented as significant public health problems in Nepal. A comprehensive approach is necessary, including introducing rubella vaccine in the routine program, assuring immunity among WCBA, strengthening routine immunization, integrating rubella surveillance with measles case-based surveillance, and establishing CRS surveillance.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666196     DOI: 10.1093/infdis/jir078

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Seroprevalence of Rubella Virus-specific Antibodies in Women and the Diagnostic Efficacy of Enzyme-linked Immunoassay and Rapid Immunochromatographic Tests.

Authors:  Praveen R Shahapur; Venkataramana Kandi
Journal:  Cureus       Date:  2020-03-12

2.  Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.

Authors:  M Carolina Danovaro-Holliday; Dale A Rhoda; Mona Lacoul; Mary L Prier; Jhalak Sharma Gautam; Tara Nath Pokhrel; Sameer Mani Dixit; Rajesh Man Rajbhandari; Anindya Sekhar Bose
Journal:  BMC Public Health       Date:  2022-02-03       Impact factor: 3.295

3.  Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania.

Authors:  Nikolas A S Chotta; Melina Mgongo; Jacqueline G Uriyo; Sia E Msuya; Babill Stray-Pedersen; Arne Stray-Pedersen
Journal:  Ital J Pediatr       Date:  2017-07-21       Impact factor: 2.638

4.  Measles and Rubella Seroprevalence in Mother-Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations.

Authors:  Alastair F Murray; Janet A Englund; James M Tielsch; Joanne Katz; Laxman Shrestha; Subarna K Khatry; Kristen Carlin; Steven C Leclerq; Mark C Steinhoff; Helen Y Chu
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

5.  Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study.

Authors:  Rihwa Choi; Yejin Oh; Youngju Oh; Sung Ho Kim; Sang Gon Lee; Eun Hee Lee
Journal:  BMJ Open       Date:  2020-01-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.